Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 4/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 4/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.47 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.47 |
| ▸ | GRIK4 | Q16099 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL287393 | 1.00 | SLC7A5 (0.50) | SLC7A5GRIA1GRIA3GRIA2GRIA4 | |
| SCHEMBL5875624 | 1.00 | SLC7A5 (0.50) | SLC7A5GRIA1GRIA3GRIA2GRIA4 | |
| SCHEMBL38374 | 0.87 | SLC7A5 (0.50) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| SCHEMBL10608422 | 0.87 | SLC7A5 (0.50) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| SCHEMBL296690 | 0.87 | SLC7A5 (0.50) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| SCHEMBL17340412 | 0.87 | GRIA1 (0.49) | SLC7A5GRIA1GRIA3GRIA2GRIA4 | |
| Hydrochloric Acid SCHEMBL10421601 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| Bromide SCHEMBL10477401 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| Bromide SCHEMBL10477399 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 | |
| Hydrochloric Acid SCHEMBL10477430 | 0.85 | SLC7A5 (0.49) | SLC7A5MAPTMEN1ALDH1A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544431-B2 | Peptides for the treatment of cancer and/or metastasis | BCN PEPTIDES, S.A. (ES) | 2026-02-10 | — | — | US | claimed |
| WO-2025044786-A1 | PEPTIDES, DERIVATIVES THEREOF, AND USE OF SAME | 南京医科大学 | 2025-03-06 | — | — | WO | claimed |
| US-20240238390-A1 | PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS | BCN PEPTIDES, S.A. (ES) | 2024-07-18 | — | — | US | claimed |
| CN-117384253-A | Peptide, derivative and application thereof | 南京医科大学 | 2024-01-12 | — | — | CN | claimed |
| EP-4069727-A1 | PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS | BCN Peptides, S.A. (ES) | 2022-10-12 | — | — | EP | claimed |
| CN-114829387-A | Peptides for the treatment of cancer and/or metastasis | BCN肽类股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| WO-2021110609-A1 | PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS | BCN PEPTIDES, S.A. (ES) | 2021-06-10 | — | — | WO | claimed |
| US-12551535-B2 | Peptide pharmaceuticals for insulin resistance | MEDERIS DIABETES, LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-12544431-B2 | Peptides for the treatment of cancer and/or metastasis | BCN PEPTIDES, S.A. (ES) | 2026-02-10 | — | — | US | disclosed |
| US-12493040-B2 | Cancer detection method using sense of smell of nematode | HIROTSU BIO SCIENCE INC. (JP) | 2025-12-09 | — | — | US | disclosed |
| US-20250325469-A1 | Inhibitors of atp synthase - cosmetic and therapeutic uses | FORREST MICHAEL DAVID (GB) | 2025-10-23 | — | — | US | disclosed |
| US-20250313604-A1 | PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | MEDERIS DIABETES LLC (US) | 2025-10-09 | — | — | US | disclosed |
| EP-3694536-B1 | A CELL-BASED SEEDING ASSAY FOR HUNTINGTIN AGGREGATION | UNIV CALIFORNIA (US) | 2025-08-27 | — | — | EP | disclosed |
| US-4495178-A | Enkephalin analogs | G. D. SEARLE & CO. (US) | 1985-01-22 | — | — | US | disclosed |
| EP-0021234-B1 | NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF LUTEINIZING HORMONE RELEASING HORMONE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SYNTEX (U.S.A.) INC. (US) | 1984-08-22 | — | — | EP | disclosed |
| US-4419347-A | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists | SYNTEX (U.S.A.) INC. (US) | 1983-12-06 | — | — | US | disclosed |
| US-4341767-A | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists | SYNTEX INC. (US) | 1982-07-27 | — | — | US | disclosed |
| EP-0049628-A2 | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists, methods of making them, and their pharmaceutical uses | SYNTEX (U.S.A.) INC. (US) | 1982-04-14 | — | — | EP | disclosed |
| EP-0021234-A1 | Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone, their preparation and pharmaceutical compositions containing them | SYNTEX (U.S.A.) INC. (US) | 1981-01-07 | — | — | EP | disclosed |
| US-4234571-A | CONTRACEPTIVES, ANTIFERTILITY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1980-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551535-B2 | Peptide pharmaceuticals for insulin resistance | IAPP, GLP1R, INSR | SLC7A5 1424/4885GRIA1 2944/4885GRIA3 3249/4885 |
| US-20250325469-A1 | Inhibitors of atp synthase - cosmetic and therapeutic uses | ATP5F1A, ATP5F1B, ATP5ME | SLC7A5 470/4885GRIA1 2295/4885GRIA3 3915/4885 |
| US-20240238390-A1 | PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS | ADAM12, ADAM17, ADAM9 | SLC7A5 1700/4885GRIA1 3453/4885GRIA3 3013/4885 |
| US-20250313604-A1 | PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | IAPP, GLP1R, PTMS | SLC7A5 2501/4885GRIA1 3134/4885GRIA3 3495/4885 |
| US-12544431-B2 | Peptides for the treatment of cancer and/or metastasis | ADAM12, PTMS, LNPEP | SLC7A5 298/4885GRIA1 1816/4885GRIA3 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.